Stock Fundamentals

Company Information

Company Name
Disc Medicine Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US2546041011
CIK: 0001816736
CUSIP: 254604101
Currency: USD
Full Time Employees: 154
Phone: 617 674 9274
Fiscal Year End: December
IPO Date: Aug 12, 2020
Description:

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

Address:

321 Arsenal Street, Watertown, MA, United States, 02472

Directors & Officers

Name Title Year Born
Dr. Donald William Nicholson Ph.D. Executive Chairman 1958
Dr. John D. Quisel Esq., J.D., Ph.D. CEO, President & Director 1971
Ms. Jean M. Franchi CPA Chief Financial Officer 1966
Mr. Jonathan Yu M.B.A. Chief Opearating Officer 1981
Dr. William Jacob Savage M.D., Ph.D. Chief Medical Officer 1974
Ms. Pamela Stephenson M.P.H. Chief Commercial Officer 1968
Dr. Brian MacDonald ChB, MB, Ph.D. Founder & Chair of Scientific Advisory Board 1961
Dr. Rahul Rajan Kaushik Ph.D. Chief Technical Officer NA
Dr. Rahul Khara J.D., Pharm.D. Chief Legal Officer & Secretary 1982
Ms. Lisa Amaya Price Chief Human Resources Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 14, 2026 Jean M Franchi N/A Sale 6.26K $69.24 $433.23K
Apr 13, 2026 William Jacob Savage N/A Sale 5.73K $66.38 $380.42K
Apr 13, 2026 Jean M Franchi N/A Sale 400.00 $69.00 $27.60K
Mar 02, 2026 William Jacob Savage N/A Sale 7.38K $65.88 $486.06K
Feb 25, 2026 Jean M Franchi N/A Sale 353.00 $69.06 $24.38K
Feb 18, 2026 Jean M Franchi N/A Sale 7.08K $65.47 $463.59K
Feb 17, 2026 Rahul Khara N/A Sale 2.85K $62.86 $179.34K
Feb 17, 2026 William Jacob Savage N/A Sale 3.26K $62.86 $204.67K
Feb 17, 2026 Pamela Stephenson N/A Sale 5.53K $62.86 $347.68K
Feb 17, 2026 Jonathan Yen-Wen Yu N/A Sale 3.23K $62.86 $203.10K
Feb 17, 2026 John D Quisel N/A Sale 13.26K $62.86 $833.78K
Feb 17, 2026 Jean M Franchi N/A Sale 4.08K $62.86 $256.15K
Jan 20, 2026 Rahul Khara N/A Sale 1.00K $69.74 $69.74K
Jan 02, 2026 Rahul Khara N/A Sale 6.50K $78.69 $511.49K
Dec 17, 2025 Kevin Bitterman N/A Sale 754.00 $91.47 $68.97K
Dec 16, 2025 Kevin Bitterman N/A Sale 68.92K $91.24 $6.29M
Dec 15, 2025 Kevin Bitterman N/A Sale 62.69K $91.28 $5.72M
Dec 15, 2025 William Jacob Savage N/A Sale 13.09K $91.22 $1.19M
Dec 15, 2025 Kevin Bitterman N/A Sale 7.00K $91.87 $643.09K
Dec 12, 2025 Kevin Bitterman N/A Sale 45.51K $92.39 $4.20M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 5.59M Mar 31, 2026 14.63% $0.02 2.51%
RA Capital Management, LLC 2.45M Mar 31, 2026 6.41% $1.66 23.99%
BlackRock Inc 2.27M Mar 31, 2026 5.95% $0.00 -0.05%
Vanguard Group Inc 1.77M Dec 31, 2025 4.63% $0.00 22.07%
Wellington Management Company LLP 1.74M Mar 31, 2026 4.54% $0.02 14.30%
State Street Corp 1.70M Mar 31, 2026 4.45% $0.00 42.95%
T. Rowe Price Associates, Inc. 1.55M Mar 31, 2026 4.06% $0.01 -8.75%
Atlas Venture Life Science Advisors, LLC 1.51M Mar 31, 2026 3.96% $12.25 0.00%
JPMorgan Chase & Co 1.37M Mar 31, 2026 3.59% $0.01 -13.26%
Frazier Life Sciences Management, L.P. 1.35M Mar 31, 2026 3.55% $2.23 7.53%
TCG Crossover Management, LLC 1.34M Mar 31, 2026 3.51% $2.45 0.00%
Bvf Inc 1.27M Mar 31, 2026 3.33% $2.59 95.74%
Orbimed Advisors, LLC 1.07M Mar 31, 2026 2.79% $1.35 0.00%
Siren, L.L.C. 988.40K Mar 31, 2026 2.59% $1.75 0.00%
Woodline Partners LP 958.28K Mar 31, 2026 2.51% $0.23 0.05%
Geode Capital Management, LLC 744.22K Mar 31, 2026 1.95% $0.00 8.65%
Vestal Point Capital LP 700.00K Mar 31, 2026 1.83% $1.25 -4.76%
Deerfield Management Co 657.00K Mar 31, 2026 1.72% $0.50 28.53%
The Goldman Sachs Group Inc 639.84K Mar 31, 2026 1.68% $0.00 -15.16%
Jennison Associates LLC 610.38K Mar 31, 2026 1.60% $0.03 14.72%

Shares Statistics

Shares Outstanding: 38.20M
Shares Float: 32.75M
% Insiders: 778.20%
% Institutions: 11,362.60%
Short % Float: 17.32%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Strategic Advisers Fidelity US TtlStk 1.81M 4.75% ▲ 9.48% Mar 31, 2026
2 State Street® SPDR® S&P® Biotech ETF 1.13M 2.96% ▼ 0.70% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 993.63K 2.60% ▲ 0.42% Apr 30, 2026
4 Fidelity Select Health Care 650.00K 1.70% ▲ 0.00% Mar 31, 2026
5 iShares Russell 2000 ETF 647.06K 1.69% ▲ 0.85% Apr 30, 2026
6 Fidelity Select Biotechnology 532.17K 1.39% ▲ 0.00% Mar 31, 2026
7 T. Rowe Price New Horizons 504.99K 1.32% ▼ 0.86% Mar 31, 2026
8 US Small-Cap Growth II Equity Comp 504.99K 1.32% ▲ 7.02% Mar 31, 2026
9 Fidelity Small Cap Growth 398.36K 1.04% ▲ 0.00% Feb 28, 2026
10 Eventide Healthcare & Life Sciences I 395.24K 1.03% ▲ 28.31% Dec 31, 2025

Valuation Metrics

Enterprise Value: $2.05B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.69B
EBITDA: $-264.40M
Book Value: $18.03
Earnings/Share: $-6.64
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -22.67%
ROE (TTM): -35.83%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 21.94x 0.04x 0.08x -65.43x -0.14x
2024-12-31 21.17x 0.06x 0.11x -226.78x -0.26x
2023-12-31 17.06x 0.00x 0.06x N/A -0.01x
2022-12-31 8.79x 0.00x 0.12x -64.42x -0.01x
2021-12-31 6.74x -0.09x 1.69x -14.33x -0.19x
2020-12-31 0.20x -0.99x 3.63x -4.99x -0.64x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IRON.US!